Please enable JavaScript to continue using this application.

Compare $CUE vs $WHWK | Chartloom

Compare

$CUE vs $WHWK

Cue Biopharma Inc · Whitehawk Therapeutics Inc

CUE

Cue Biopharma Inc

WHWK

Whitehawk Therapeutics Inc

Compare $CUE vs $WHWK

Comparing Cue Biopharma Inc and Whitehawk Therapeutics Inc

CUECue Biopharma Inc

WHWKWhitehawk Therapeutics Inc

CUECue Biopharma Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

354.4%

YTD performance

173.6%

52W performance

7.5%

FCF yield

-44.8%

WHWKWhitehawk Therapeutics Inc

Market cap

$189M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

44.3%

52W performance

65.3%

FCF yield

-36.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CUE

WHWK

Detailed metrics comparison

CUE

Cue Biopharma Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

CUE$112M

WHWK$189M

Enterprise Value

CUE$95M

WHWK$104M

Price

CUE$27.66

WHWK$3.52

P/E Ratio

CUEN/A

WHWKN/A

P/S Ratio

CUE2.98x

WHWK7.56x

EV/Sales

CUE2.51x

WHWK0.00x

EV/EBITDA

CUE0.00x

WHWK0.00x

P/B Ratio

CUE80.41x

WHWK1.15x

P/FCF Ratio

CUEN/A

WHWKN/A

EV/FCF

CUE-1.89x

WHWK-1.50x

PEG Ratio

CUEN/A

WHWKN/A

Forward P/E (NTM)

CUEN/A

WHWKN/A

Forward P/S (NTM)

CUEN/A

WHWKN/A

Revenue (TTM)

CUE$38M

WHWK$0

Revenue Growth (YoY)

CUE354.4%

WHWK-100.0%

Forward Rev Growth

CUE-38.2%

WHWK167.6%

Gross Margin (TTM)

CUE0.0%

WHWK88.7%

Operating Margin (TTM)

CUE0.0%

WHWK87.4%

EBITDA Margin (TTM)

CUE-258.4%

WHWK0.0%

Net Margin (TTM)

CUE-435.8%

WHWK99.4%

FCF Margin (TTM)

CUE-133.2%

WHWKN/A

Net Income (TTM)

CUE$-164M

WHWK$-80M

FCF (TTM)

CUE$-50M

WHWK$-69M

EPS (TTM)

CUE-$25.88

WHWK-$0.96

ROE (TTM)

CUE-103219.0%

WHWK-5389.0%

ROA (TTM)

CUE-48467.0%

WHWK-4997.0%

ROIC (TTM)

CUE-100612.0%

WHWK-5389.0%

Cash

CUE$17M

WHWK$85M

Debt

CUE$0

WHWK$0

Net Cash/Debt

CUE$17M

WHWK$85M

Current Ratio (TTM)

CUE1.25x

WHWK17.38x

Quick Ratio (TTM)

CUE1.16x

WHWK17.16x

Debt/Equity (TTM)

CUE0.00x

WHWK0.00x

Debt/Assets (TTM)

CUE0.0%

WHWK0.0%

Interest Coverage (TTM)

CUEN/A

WHWKN/A

Net Debt/EBITDA (TTM)

CUE0.00x

WHWK0.00x

Beta

CUE2.84

WHWK0.99

52W Performance

CUE7.5%

WHWK65.3%

YTD Performance

CUE173.6%

WHWK44.3%

% from 52W High

CUE-39.2%

WHWK-35.9%

% from 52W Low

CUE456.4%

WHWK88.2%

Asset Turnover (TTM)

CUE1.11x

WHWK0.23x

FCF Yield (TTM)

CUE-44.8%

WHWK-36.6%

Earnings Yield (TTM)

CUE-146.5%

WHWK-42.2%

Dividend Yield (TTM)

CUEN/A

WHWKN/A

Rule of 40

CUE221.1

WHWK-100.0

EV/GP/RG

CUEN/A

WHWKN/A

Ticker research

View CUE research View WHWK research

Metric	CUE Cue Biopharma Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$112M	$189M
Enterprise Value	$95M	$104M
Price	$27.66	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	7.56x
EV/Sales	2.51x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$38M	$0
Revenue Growth (YoY)	354.4%	-100.0%
Forward Rev Growth	-38.2%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-258.4%	0.0%
Net Margin (TTM)	-435.8%	99.4%
FCF Margin (TTM)	-133.2%	N/A
Net Income (TTM)	$-164M	$-80M
FCF (TTM)	$-50M	$-69M
EPS (TTM)	-$25.88	-$0.96
ROE (TTM)	-103219.0%	-5389.0%
ROA (TTM)	-48467.0%	-4997.0%
ROIC (TTM)	-100612.0%	-5389.0%
Financial Health
Cash	$17M	$85M
Debt	$0	$0
Net Cash/Debt	$17M	$85M
Current Ratio (TTM)	1.25x	17.38x
Quick Ratio (TTM)	1.16x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	0.99
52W Performance	7.5%	65.3%
YTD Performance	173.6%	44.3%
% from 52W High	-39.2%	-35.9%
% from 52W Low	456.4%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.23x
FCF Yield (TTM)	-44.8%	-36.6%
Earnings Yield (TTM)	-146.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View CUE research	View WHWK research

Valuation

P/S Ratio

CUE

2.98x

WHWK

7.56x

EV/FCF

CUE

-1.89x

WHWK

-1.50x

Growth & revenue

Revenue Growth TTM

CUE

354.4%

WHWK

-100.0%

Forward Revenue Growth

WHWK

167.6%

CUE

-38.2%

Profitability & performance

Gross Margin

WHWK

88.7%

CUE

0.0%

ROE

WHWK

-5389.0%

CUE

-103219.0%

FCF Yield %

WHWK

-36.6%

CUE

-44.8%

52-Week Performance

WHWK

65.3%

CUE

7.5%

Detailed metrics comparison

CUE

Cue Biopharma Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

CUE$112M

WHWK$189M

Enterprise Value

CUE$95M

WHWK$104M

Price

CUE$27.66

WHWK$3.52

P/E Ratio

CUEN/A

WHWKN/A

P/S Ratio

CUE2.98x

WHWK7.56x

EV/Sales

CUE2.51x

WHWK0.00x

EV/EBITDA

CUE0.00x

WHWK0.00x

P/B Ratio

CUE80.41x

WHWK1.15x

P/FCF Ratio

CUEN/A

WHWKN/A

EV/FCF

CUE-1.89x

WHWK-1.50x

PEG Ratio

CUEN/A

WHWKN/A

Forward P/E (NTM)

CUEN/A

WHWKN/A

Forward P/S (NTM)

CUEN/A

WHWKN/A

Revenue (TTM)

CUE$38M

WHWK$0

Revenue Growth (YoY)

CUE354.4%

WHWK-100.0%

Forward Rev Growth

CUE-38.2%

WHWK167.6%

Gross Margin (TTM)

CUE0.0%

WHWK88.7%

Operating Margin (TTM)

CUE0.0%

WHWK87.4%

EBITDA Margin (TTM)

CUE-258.4%

WHWK0.0%

Net Margin (TTM)

CUE-435.8%

WHWK99.4%

FCF Margin (TTM)

CUE-133.2%

WHWKN/A

Net Income (TTM)

CUE$-164M

WHWK$-80M

FCF (TTM)

CUE$-50M

WHWK$-69M

EPS (TTM)

CUE-$25.88

WHWK-$0.96

ROE (TTM)

CUE-103219.0%

WHWK-5389.0%

ROA (TTM)

CUE-48467.0%

WHWK-4997.0%

ROIC (TTM)

CUE-100612.0%

WHWK-5389.0%

Cash

CUE$17M

WHWK$85M

Debt

CUE$0

WHWK$0

Net Cash/Debt

CUE$17M

WHWK$85M

Current Ratio (TTM)

CUE1.25x

WHWK17.38x

Quick Ratio (TTM)

CUE1.16x

WHWK17.16x

Debt/Equity (TTM)

CUE0.00x

WHWK0.00x

Debt/Assets (TTM)

CUE0.0%

WHWK0.0%

Interest Coverage (TTM)

CUEN/A

WHWKN/A

Net Debt/EBITDA (TTM)

CUE0.00x

WHWK0.00x

Beta

CUE2.84

WHWK0.99

52W Performance

CUE7.5%

WHWK65.3%

YTD Performance

CUE173.6%

WHWK44.3%

% from 52W High

CUE-39.2%

WHWK-35.9%

% from 52W Low

CUE456.4%

WHWK88.2%

Asset Turnover (TTM)

CUE1.11x

WHWK0.23x

FCF Yield (TTM)

CUE-44.8%

WHWK-36.6%

Earnings Yield (TTM)

CUE-146.5%

WHWK-42.2%

Dividend Yield (TTM)

CUEN/A

WHWKN/A

Rule of 40

CUE221.1

WHWK-100.0

EV/GP/RG

CUEN/A

WHWKN/A

Ticker research

View CUE research View WHWK research

Metric	CUE Cue Biopharma Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$112M	$189M
Enterprise Value	$95M	$104M
Price	$27.66	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	2.98x	7.56x
EV/Sales	2.51x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	80.41x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.89x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$38M	$0
Revenue Growth (YoY)	354.4%	-100.0%
Forward Rev Growth	-38.2%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-258.4%	0.0%
Net Margin (TTM)	-435.8%	99.4%
FCF Margin (TTM)	-133.2%	N/A
Net Income (TTM)	$-164M	$-80M
FCF (TTM)	$-50M	$-69M
EPS (TTM)	-$25.88	-$0.96
ROE (TTM)	-103219.0%	-5389.0%
ROA (TTM)	-48467.0%	-4997.0%
ROIC (TTM)	-100612.0%	-5389.0%
Financial Health
Cash	$17M	$85M
Debt	$0	$0
Net Cash/Debt	$17M	$85M
Current Ratio (TTM)	1.25x	17.38x
Quick Ratio (TTM)	1.16x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.84	0.99
52W Performance	7.5%	65.3%
YTD Performance	173.6%	44.3%
% from 52W High	-39.2%	-35.9%
% from 52W Low	456.4%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	1.11x	0.23x
FCF Yield (TTM)	-44.8%	-36.6%
Earnings Yield (TTM)	-146.5%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	221.1	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View CUE research	View WHWK research